Based on the above inference, SNORD126, which is both an oncogene and a viral infection-promoting element, could serve as a potential diagnostic and therapeutic target during different phases of this pathological process, enhancing the clinical application value of this snoRNA. Here, SNORD126 is linked to viral infectious disease.